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S ynovial Fluid Lipids in Normal Individuals and Patients 
with Rheumatoid Arthritis 
By GILES G.  BOLE 
With the technical assistance of Dorothy F .  Peltier 
Normal human synovial fluid contains 
trace amounts of phospholipids and 
cholesterol. Phospholipid composition is 
similar to that in serum. Rheumatoid 
synovial fluid contains increased amounts 
of phospholipid, cholesterol, and neutral 
lipids. In  most cases the concentration 
is 40 to 60 per cent of that found in 
simultaneously collected serum speci- 
mens. A direct relationship appears to 
exist between total synovial fluid pro- 
tein and lipid concentration. No rela- 
tionship could be established between 
lipid content in rheumatoid synovial 
fluid, and totaI cell content, hyaluronic 
acid, severity or duration of synovitis 
in the involved joint. 
Normal liquido synovial in humanos 
contine quantitates tracia de phospho- 
lipidos e de cholesterol. Iste phospho- 
lipidos es simile in composition a illos 
del sero. Le liquido synovial ab patientes 
rheumatoide contine augmentate quan- 
titates de phospholipido, de cholesterol, 
e de lipidos neutre. In le majoritate del 
casos, le concentration es 40 a 60 pro 
cento de ill0 trovate in simultaneemente 
colligite specimens de sero. Un relation 
directe pare exister inter le proteina 
total e le concentration lipidic in le 
liquido synovial. Nulle relation poteva 
esser establite inter le contento de 
lipidos in liquido synovial ab patientes 
rheumatoide e le parametros del total 
contento cellular, de acido hyaluronic, 
e del severitate o del duration de 
synovitis in le afficite articulation. 
NTEREST in further studies on the lipids of rheumatoid synovial fluid I was prompted by increasing evidence that a variety of cells synthesize both 
neutral lipids and phospholipids. Of considerable importance is the suggestion 
that several types of cells can contribute to extracellular lipid concentration. 
Recent investigations by Buchanan,l and Marks2 have shown that leukocytes 
possess this capacity. Preliminary reports by Jackson3 indicate the cells of 
the carrageenin granuloma synthesize lipids, and studies in this laboratory4 
indicate that the cells of the polyvinyl granuloma will incorporate glycerol-C14 
into phospholipids and neutral lipids. By comparing the lipid composition of 
serum with that of the cells, and the cell poor fraction of synovial fluid, it was 
hoped that additional information as to the source of these lipids might be 
obtained. 
Over a century ago Frerichs5 reported that traces of fat were present in 
bovine synovial fluid. Ropes and Bauers found no lipid in bovine fluid, but did 
report the presence of cholesterol in rheumatoid joint fluid. It was their impres- 
sicn that synovial lipids accumulated in joints where excessive tissue destruc- 
tion had occurred. This observation was in agreement with earlier work by 
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Kling7 indicating that fat occurred only in traumatic effusions or at the nidus 
of “rice bodies” resulting from inflammatory degenerative changes in the 
synovium. 
Recently, Schmid and McNairsr9 have reported detailed studies of the 
protein composition of synovial fluid. They found q- and P1-lipoproteins, 
identified by their cholesterol content, present in traumatic synovitis and a 
pooled specimen of rheumatoid fluid, and trace amounts in synovial fluid 
obtained postmortem from patients without apparent joint disease. Most re- 
cently, Chung and associateslo have reported on the lipid composition of fluids 
obtained from patients with rheumatoid arthritis and osteoarthritis. These in- 
vestigators have suggested that synovial cells may synthesize some of the lipids 
found in synovial fluid. 
METHODS AND MATERIALS 
Clinical 
Threc pools of hnman synovial fluid ( 2  to 3 cc. each) obtained from the knee joints of 
normal volunteers were available for study.* S y n o d  fluid was also obtained from 24 
patients with classical rheumatoid arthritis,ll two patients with juvenile rheumatoid arthritis 
(19 and 24 years of age at the time of study), one patient with psoriatic arthritis and one 
with monoarticular rheumatoid arthritis. Simultaneous blood specimens were obtained in 
most cases. Eleven of the patients had received intra-articular hydrocortisone tertiary- 
butylacetate 1 to 2 months prior to aspiration of the specimen used in this study. Six of 
the patients were receiving maintenance gold therapy, and one patient was on 2.5 mg. of 
prednisone per clay. Acute synovitis characterized by recent increase in effusion, definite 
erythema, local heat, pain, and tenderness was present in 15 of the nonsteroid treated pa- 
tients. Two-thirds of these individuals had had synovitis in the aspirated joint for less than 
24 months. Four of the steroid treated patients had acute synovitis. The remainder had 
chronic indolent effusions, all but one of these having been prcsent for 2 to 15 years. 
Anal ytico’l 
An aliquot of fluid was removed for routine laboratory studies and the remainder of the 
joint fluid and simultaneously collected serum were then subjected to low speed centrifuga- 
tion. The cell-poor fraction of synovial fluid was promptly removed and stored with the 
cell pellet, and serum at -20 C. until analysis. Seven of the synovial fluid specimens were 
lyophilized and weighed aliqnots subjected to chloroform-methanol extraction.12 The ex- 
tract was washed with 0.2 volume of water and the aqneous phase discarded. The organic 
layer was dried by vacuum desiccation and its weight determined. The remainder of the 
specimens were extracted by the method of Sperry and Brand.’:? The methods used in 
this laboratory for phosphorus, cholesterol, total ester, nitrogen, and ninhydrin nitrogen 
have been reported previously.14 The method of calculation of the several lipid groups is in 
agreernent with that of Phillips15 and has been reported.14 Details of the procedure for 
quantitative silicic acid paper chromatography and qualitative detection of phospholipids by 
rhodamine, choline, and ninhydrin staining have recently been reviewed by Marinetti.lG 
Silicic acid column chromatography utilizing step-wise gradients of chloroform and 
methanol combined with paper chromatography was employed as described by Marinetti 
and co-workers.17 Cholesterol and cholesterol ester were determined by the method of 
Kingsley and Schaffert.18 Total protein in the serum and synovial fluid was measured by 
“The author is indebted to the authorities and inmates, Federal Correctional Institution, 
Milan, Mich. and to Dr. I. F. Duff, Physician in Charge, Rackham Arthritis Research Unit, 
for making this material available for study. 
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Table 1.-Normal Human Synovial Fluid 
Milligrams uer cc. 
Hyalumnic Total Neutral 
poo: Protein Acid Phospholipid Cholesterol Lipid 
1 21.7 3.18 0.130 - - 
2 16.3 2.64 0.150 0.075 0 
3 16.1 2.66 0.135 0.066 0 
Mean: 18.0 2.83 0.138 0.071 0 
ultraviolet absorption at 215 and 225 inp as described by Waddell.19 Total mucopolysac- 
charide content of the synovial fluid specimens (hyaluronate, as uronic acid) was determined 
as follows: a 1:25 dilution of the specimen was carried out, 1 cc. of the diluted material 
was extracted with an equal volume of 20 per cent trichloroacetic acid. This was brought 
to 100 C .  in a boiling water bath to precipitate protein. A measured aliquot was centrifuged 
at 10,000 rpin and an aliquot of the supernatant was utilized for carbazole reaction.20 
RESULTS 
Normal H u m n  Synovial Fluid 
Two of the normal human synovial fluid pools were extracted by the method 
of Sperry, the third by the method of Folch. The values for total protein, hyal- 
uronic acid, and lipids are given in table 1. Satisfactory agreement was ob- 
tained between the three pools. Hydroxamate reactive ester was detected in 
two pools, and all of it could be accounted for as phospholipid ester. Based 
upon this determination, no neutral ester was present. The data for quantitative 
silicic acid paper chromatography of phospholipids are included in table 3 and 
will be discussed in reference to the other specimens analyzed. Qualitatively 
the choline spot test indicated the presence of three components corresponding 
to lecithin, sphingomyelin, and lysolecithin. Ninhydrin reactivity was limited 
to a faint spot at the origin of the chromatograms. 
Rheumatoid Syrwvial Fluid 
a. Total lipids: In four patients who had never received intra-articular 
steroids, total lipids constituted 4.2 per cent of the total solids in two patients, 
4.1 per cent in another, and 8.8 per cent in the fourth. In three patients who 
had received intra-articular steroids, total lipid expressed as per cent of total 
solids was 9.0, 9.5, and 10.9 per cent respectively. 
b. Total phospholipid, cholesterol, and neutral lipids: Serum values for 
these substances were determined in this laboratory for a small number of 
normals, using the analytical procedures employed in this study. They were 
in general agreement with those recently published by Phillips,'K and Mellin- 
koff and associates21 for the major lipid groups. In figure lA,  data for total 
phospholipid, cholesterol, and neutral ester are given in mg./cc. of rheumatoid 
synovial fluid. In figure lB, values for the cell-poor fraction of rheumatoid 
synovial fluid are expressed as per cent of simultaneously determined serum 
values for the same constituents. Specimens obtained from patients untreated 
with intraarticular steroids ( 0 )  have been segregated from those that had re- 
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Fig. 1.-A. Mean and range of values for total phospholipid, cholesterol, and 
neutral lipid in the cell-poor fraction of individual specimens of rheumatoid synovial 
fluid from the knee joint. B. The same components expressed as a percentage of 
the concentration found in simultaneously obtained serum specimens. 0-patient 
had never received intra-articular steroids, S-previous treatment with intra-articular 
steroids. 
phospholipid was 0.84 mg./cc.; total cholesterol, 1.25 mg./cc.; and neutral 
lipid, 0.80 mg./cc. In 14 untreated patients, total phospholipids, cholesterol 
and neutral ester constituted 47.8, 49.6, and 42.4 per cent of the simultaneously 
determined serum value. In nine of the steroid treated cases the mean value 
for total phospholipid, cholesterol, and neutral ester was 43.3, 40.8, and 30.4 
per cent, respectively. Again, the range of values is extremely broad. In all 
patients, the value for each lipid group was lower than that for serum. In most 
instances, the value was 40 to 60 per cent of the serum level. 
Total phospholipid, cholesterol, neutral ester, and total lipid determinations 
on the extract from the cell pellet accounted for less than 10 per cent of the 
value obtained on the cell-poor fraction of synovial fluid. Total cell counts 
per cu. mm. on these specimens ranged from 3500 to 47,500 with a mean of 
14,000. From the volume of synovial fluid utilized the total number of cells 
extracted was calculated, and it was evident that total lipid present exceeded 
the amount that could be accounted for intracellularly. Cholesterol and neutral 
lipids contributed most to this discrepancy. Values for pellets that were washed 
repeatedly with cold physiologic saline prior to extraction were definitely 
lower but still exceeded those given for red cells.22 Total phospholipid phos- 
phorus approximated that in human synovial cells.23 Qualitative silicic acid 
paper chromatography of this fraction of synovial fluid demonstrated the 
presence of both phosphatidylethanolamine and phosphatidylserine ( cephalin 
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Table 2.-Percentage Composition-Pooled Specimens of 
Rheumatoid Synovial Fluid 
Total Eeter Free Ester* 
Phospholipids Cholesterol Cholesterol Fraction “Triglyceride” 
Blood 
Mean 37.5 33.5 14.7 0.70 17.8 
Range (34.1-43.9) (27.8-38.0) (11.3-18.7) (.67-.77) (11.8-24.2 
Synovial Fluid 
Mean 38.3 41.5 15.1 0.73 6.4 
Range (35.0-42.5) (21.7-54.0) (3.5-28.3) (.43-.82) (0-14.5) 
‘Corrected ester + corrected total cholesterol concentration ( 18) .  
Table 3.-Percentage Composition of Phospholipids Rheumatoid Serum, Synovial 
Fluid, Cell Pellets, and Normal Synovial Fluid 
No. De- 
Uniden- termi- 
Lecithin myelin lecithin inositide “Cephalins” tified nations 
Sphingo- LYBO- Phospho- 
Serum 
Mean 51.3 28.9 9.8 1.8 2.4 7.2 5 
Range (45.3-59.8) (21.4-33.7) (4.4-14.4) (0-7.7) (0-6.4) (0-14.2) 
Synovial Fluid 
Normal 
Mean 61.2 19.4 6.8 3.0 1.2 8.3 3 
Range (57.9-64.5) (13.1-25.6) (4.2-9.3) (0-6.0) (0-2.4) (6.9-9.8) 
Rheumatoid 
No steroid 
Mean 52.7 26.3 9.8 2.9 1.8 10.0 6 
Range (45.6-58.6) (11.8-39.0) (6.6-16.8) (0-5.4) (0-4.5) (0.1-16.8) 
Rheumatoid 
Steroid 
Mean 60.9 22.8 9.0 1 .o 6.0 1.1 6 
Range (54.1-68.2) (19.1-27.6) (5.2-10.6) (0-2.0) ( 1.3-7.9) (0-6.4) 
Mean 49.1 24.9 0.9 8.3 3.7 11.3 6.7 6 
Range (38.8-60.0) (13.641.8) (0-3.4) (5.7-10) (0-6.0) (6.4-18.5) (4.7-9.6) 
Synovial Pellet Mono- Di-(7) 
phospholipids). The quantitative data for the individual phospholipids are 
given in table 3. 
c. Esterified cholesterol and “triglyceridd” constituents: Total lipid extracts 
of serum and of the cell-poor fractions of synovial fluid from several of the pa- 
tients were combined and studied in duplicate. In addition, the chloroform 
eluate from two similar specimens from serum and synovial fluid were analyzed 
following silicic acid column chromatography. Mean percentage composition 
and range of four separate determinations for the major lipids of blood and 
synovial fluid are given in table 2. Values obtained on the two pooled total 
extracts were in agreement with those obtained on the chloroform eluate from 
silicic acid columns. Only the neutral lipid content (cholesterol ester and 
triglycerides) appeared to differ from that found in serum. Esterified choles- 
terol was higher, while the ester fraction of total cholesterol in synovial fluid 
varied more than that for serum. The derived value for triglyceride in blood of 
17.8 per cent contrasts with that of 6.4 per cent for synovial fluid. In one of 
the synovial fluid pools, no triglyceride was present. However, the range of 
values for triglyceride in serum and synovial fluid overlapped. This study on 
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the pool specimens would indicate that the major proportion of neutral lipid 
in the cell-poor fraction of synovial fluid was esterified cholesterol. 
d. Chromatogiiaphy of phospholipids: In table 3, values are given for per- 
centage composition of individual phospholipids as determined by quantitative 
silicic acid paper chromatography. For comparative purposes, phosphoIipid 
composition of five rheumatoid cell pellets and three normal synovial fluid 
pools are included with values for rheumatoid serum and synovial fluid. Un- 
identified phosphorus is recorded at the extreme right of the table. This value 
expresses the efficiency of recovery of total phospholipid phosphorus applied 
to the chromatograms. It can be seen that recovery varied between 84 and 
100 per cent, and was greater than 90 per cent for most of the analyses. The 
mean concentration of individual phospholipids was similar for rheumatoid 
serum and the cell-poor fraction of synovial fluid. The range of observed values 
overlapped in each instance. In normal fluid the mean values for sphingomyelin 
and lysolecithin were definitely lower, while the monophosphoinositide value 
was slightly higher than that for the pathologic specimens. The composition of 
phospholipids in the cell pellets of five synovial fluid specimens demonstrates: 
an extremely low content of lysolecithin, a moderate cephalin phospholipid 
level, and a relatively high level of phosphoinositide which has been segregated 
into mono- and di-phosphate components. This refers to material chroma- 
tographing with characteristics of these two species of phosphoinositide.16 
The amount of material available did not allow more definitive identification of 
these inositide fractions. 
Silicic acid column chromatography done on a pooled specimen of lipid ex- 
tract from the cell-poor fraction of synovial fluid of seven rheumatoid patients 
and on a similar pool from serum is shown in figure 2. Striking similarity of 
the elution pattern for each is evident. Results of rechromatography of aliquots 
from each of the fraction tubes on silicic acid impregnated paper is also given. 
The early small cephalin peak contains both phosphatidylethanolamine and 
phosphatidylserine, as well as monophosphoinositide. It is evident that the 
analysis of total phosphorus from column fractionation may include more 
than one individual phospholipid in several of the column peaks. This finding 
is in agreement with the reports of WallachZ4 and Reed.22 By repeat chrom- 
atography of phospholipids obtained from these columns, percentage composi- 
tion of the individual phospholipids can be obtained and is also given in figure 
2. These values are similar to those of Nye17 for plasma using combined silicic 
acid column and paper chromatography. Total phosphorus in the synovial 
fluid cephalin peak was 0.5 pmole of which 0.31 pmole was ninhydrin reactive. 
This was in agreement with repeat determination by paper chromatography 
which demonstrated that “cephalins” constituted 0.33 pmole of this peak. The 
remainder was monophosphoinositide. The elution pattern for major phospho- 
lipids and the percentage composition of individual phospholipids from serum 
and synovial fluid are very similar. 
e. Sequential studies of the lipid content in  rh,eumatoid synoviul fluid: Fol- 
low-up analysis on synovial fluid lipids was carried out in four patients (table 
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Table 4.--Sequential Analyses of Synovial Fluid Lipids in Rheumatoid Arthritis _____ 
mg. per cc. Clinical Status: 
Hyal- Interval 
Phospho- Choles- Neutral Total uronic Total Cells Since Last 










2,800 .87 1.49 .91 3.20 - 
.43 .78 .36 1.57 .56 59.6 4,700 
.90 1.21 .64 2.76 - 59.1 6,850 
.76 1.07 .50 2.47 1.31 49.5 3,550 
.93 1.32 ,638 3.00 - 44.1 41,900 
.86 1.44 .73 3.03 .96 40.9 24,000 
. 6 i  1.77 1.19 3.63 - - 23,600 
.77 1.85 .50 3.12 - - - 



















*RK and LK-right and left knee. 
ovitis of 6 months’ duration, lipid content decreased significantly in 7 days, 
while the total cell count had doubled. Patients 2 and 3 with classic rhceumatoid 
arthritis of long duration (7  and 13 years) had received intra-articular steroids 
on multiple previous occasions. Lipid content was remarkably stable in the 
same, and the opposite knee during the time intervals indicated in table 4. 
In patient 4, with classic rheumatoid arthritis of 4 years’ duration, gold therapy 
was initiated after the first fluid analysis. At that time the patient was ex- 
periencing a severe flare of her disease. Four months later, a second analysis 
revealed decreased neutral lipid content; during this interval the signs of 
acute synovitis had regressed. Sixteen months later this patient was clinically 
in remission, although a chronic asymptomatic effusion persisted in the op- 
posite knee. The lipid content in the right knee was similar, with low neutral 
lipid, to that found months previously in the left knee. No consistent pattern 
NO STEROID 0 
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Fig. 3.-Concentration of total phospholipid and hyaluronic acid determined 
simultaneously in 14 rheumatoid patients, and three pools of normal human 
synovial fluid. Patients who had received prior intra-articular steroid (x) , and non- 
steroid treated ( 0 )  patients. 
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PROTEIN M g m l c c  
Fig. 4.-Concentration of total phospholipid, and total protein determined simul- 
taneously in 15 rheumatoid patients, and three pools of normal human synovial 
fluid. The clinical status of the patient at the time of aspiration of the knee is 
indicated in the figure. See text for details. J-juvenile rheumatoid arthritis. 
of response is apparent from these few sequential studies. Stability of the lipid 
values is evident in steroid treated patients, except perhaps for neutral lipid 
content. In the single untreated patient with acute synovitis, the level of lipids 
changed during an interval of 1 week. 
f. Non-lipid constituents: cells, hyaluronic acid, and proteins: The total cell 
count in synovial fluid was unrelated to the level of any of the lipid constituents 
in the cell-poor fraction of synovial fluid. 
In figure 3, concentration of total phospholipid is plotted against the con- 
centration of hyaluronic acid in 14 patients in whom it was simultaneously 
determined. The data have been segregated for those patients treated with 
steroids and those that had never received intra-articular steroids. The three 
normal pools are also included. Very little, if any, correlation existed between 
concentration of total phospholipid and mucopolysaccharide in the synovial 
fluid from these patients. No relationship could be established between total 
cholesterol or total neutral lipids and hyaluronic acid concentration in synovial 
fluid. 
In figure 4, total protein is plotted against total phospholipids found in the 
cell-poor fraction of synovial fluid. At the extreme lower left of the figure, 
values for the three normal fluid pools are shown. Taking this as an arbitrary 
point of reference, some relationship between total protein and total phospho- 
lipid concentration appears to exist. The five points that appear to be most 
divergent in this plot include two patients with juvenile rheumatoid arthritis 
( J ) ,  and two with advanced rheumatoid arthritis of long duration. Two de- 
terminations were done on one of these patients. Both had received repeated 
injections of intra-articular steroid. Plotting total cholesterol or total neutral 
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ester against protein gave a comparable relationship. The same five specimens 
appeared most divergent from the other determinations. In general, the level 
of protein was highest in those having the highest total lipid content. 
DISCUSSION 
It is evident from table 1 that the lipid concentration is extremely low in 
normal human fluid. The presence of only trace amounts of phospholipid in 
normal fluid, even smaller quantities of total sterol, and the absence of neutral 
lipid contrasts sharply with the concentrations found in serum. It is signif- 
icantly difFerent from the increased content found in the cell-poor fraction of 
rheumatoid synovial fluid. The content of cholesterol in normal fluid agrees 
well with that reported by Schmid and M ~ N a i r . ~  The small quantities of phos- 
pholipid present in normal synovial fluid has a qualitative distribution very 
similar to that of human p1asma.l’ In the normal state, lipids (lipoproteins) ap- 
pear to be prevented from freely entering the synovial cavity. In rheumatoid 
arthritis, the level of all lipids in synovial fluid increases significantly. In most 
cases triglyceride content increases less than that for phospholipids and choles- 
terol. 
No attempt has been made to relate these data in rheumatoid patients to 
various classes of lipoproteins segregated by electrophoresis, Cohn fractiona- 
tion, or ultracentrifugation. Difficulties inherent in making such a comparison 
have been discussed by Bragdon,25 Hillyard,26 and Phillips.27 Chung, Shanahan, 
and Brownlo concluded from their recent study of lipids of serum and synovial 
fluid from 12 rheumatoid and eight patients with degenerative arthritis that 
phospholipid composition and ratio of total cholesterol to phospholipid in syn- 
ovial fluids differed from serum, and were characteristic of serum lipoproteins 
of density < 1.063. In two patients with degenerative joint disease they studied 
the phospholipid composition of a- and &lipoproteins separated by starch 
block electrophoresis, and felt that the differences were even more significant. 
They suggested that these differences might result from “absorption rate differ- 
ences for different classes of lipoproteins,” or be contributed by the synovial 
membrane itself. 
In the present investigation a concentration difference for lipids persists be- 
tween serum and the cell-poor fraction of rheumatoid synovial fluid. The ratio 
is similar to that reported by Chung.lo The composition of lipids found in the 
blood and synovial fluid is similar qualitatively (table 2 ) .  The percentage 
composition of phospholipids in serum, normal joint fluid, and rheumatoid 
synovial fluid before or after intra-articular steroids, as determined by silicic 
acid paper chromatography, is comparable (table 3 ) .  The range of variability 
observed for each phospholipid might account for this apparent similarity. 
However, variance of this degree does not occur when a single specimen is 
subjected to replicate analyses. Using comparable technics, Nye and Water- 
house2* reported levels for the three major phospholipids of serum in a group 
of chronic nephrotics which varied as widely as the values for our rheumatoid 
patients. This has also been found true for patients with liver disease.29 The 
values for phospholipids in pooled lipid extracts (fig. 2) of serum and synovial 
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fluid determined by combined silicic acid column and paper chromatography 
differ slightly from those discussed above. All of the values fall within the 
range observed for the individual specimens, but make it evident that moder- 
ate differences in concentration require cautious interpretation. 
From these data it is impossible to assess the significance of these change; 
in relation to the physical state of native lipoproteins. In most of our patients 
the concentration of the major lipid groups in rheumatoid synovial fluid ap- 
peared to relate grossly to the total protein concentration. This has been re- 
ported to be the most consistent relationship observed by Nette1bladt:O and 
Pigman3I for sialic acid containing glycoproteins identified in pathologic syn- 
ovial fluid. Whether the protein to lipid relationship noted for the two juvenile 
rheumatoids and two chronic, intra-articular steroid treated patients reflects 
a true difference from that for the majority remains undetermined. Although 
speculative, one explanation for this could be that in pathologic synovial fluid 
different lipoproteins occur than are found in serum. Proof of this hypothesis 
is not yet available. 
If cell degeneration and breakdown contributed in any major way to the 
lipid content of rheumatoid fluid, it would be anticipated that the “cephalin” 
level should approximate 20-30 per cent as found for a variety of intact 
ce11s.22~24,32 The value was consistently less than 5 per cent for the cell-poor 
fraction of synovial fluid. The cell pellets separated by initial centrifugation 
contained less than 10 per cent of the total lipid, and no correlation between 
lipid concentration and total cell count in synovial fluid could be established. 
In addition, the lipid concentration in most cf the rheumatoid synovial fluids 
studied was unrelated to duration of disease or degree of local inflammation. 
The present study and Chung’s data1” would indicate that most of the lipid 
in synovial fluid must in some way be derived from the blood; however, a 
gradient of difference in total concentration exists in all of the patients included 
in this study. By contrast, studies of experimentally induced granulation tis- 
sue3-4,33 have shown that local synthesis, as well as presumed changes in 
vascular permeability, contribute to tissue lipid concentration. Both of these 
factors may effect the concentration and composition of lipids present in 
pathologic synovial fluids. Based upon current observations, changes in perme- 
ability would appear to be the more important in human disease. 
SUMMARY 
The composition of the lipids in normal human fluid and in 28 patients 
with rheumatoid arthritis have been described. The lipid concentration in 
normal fluid was extremely low, whiIe concentration of the major lipid 
groups in the cell-poor fraction of rheumatoid synovial fluid constituted in 
most cases 40-60 per cent of the level in the serum. Pleocytosis in the fluid 
contributes only to a minimal degree to the total concentration. A direct 
relationship between total protein concentration and the major lipid constitu- 
ents found in synovial fluid appeared to exist. No clear association between the 
use of steroids, severity of disease or total mucopolysaccharide content could 
be established. 
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